Last November’s election ushered in a new administration, a new Congress, and a new political agenda. One of the Trump ...

The United States is amid a dangerous drug shortage. It’s a crisis that endangers patients, undermines our health care system ...

The U.S. Food and Drug Administration is suspending efforts to improve its bird flu testing of milk, cheese and pet food due ...

Vivex Biologics chairman John McCallum breaks down the challenges, costs, and strategies behind bringing medical innovations ...

You can't build a drug empire on your own in Schedule 1, and that's where dealers come into play. As you grow your network of ...

The justices unanimously overturned a 5th Circuit decision that deemed the agency's treatment of e-liquids "arbitrary and ...

Seven lots of Tony's Chocolonely Everything bar and Dark Chocolate Almond Sea Salt bar have been recalled over concerns that the candy may contain small stones, according to the U.S. Food and Drug ...

Steinkühler: AI presents a tremendous opportunity in the field of finance, primarily because it facilitates the use and ...

Analysts said tariffs would send prescription drug prices higher. Generic drugs and ingredients that are largely made ...

Can a robot help prepare cancer medication in a hospital pharmacy? That's what hospital pharmacist Tjerk Geersing ...

Although HHS says it did not target FDA product reviewers or inspectors, FDA employees who assist with reviews in various capacities were let go, including project managers and staff in administration ...

Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.